EQT Life Sciences’ Health Economics 3 Fund

Investor: British Business Bank

The British Business Bank (BBB) has announced a significant commitment of £21.26 million (€25 million) to EQT Life Sciences’ Health Economics 3 Fund (EQT HE3). This investment is designed to foster innovation within Europe and enhance capital flow into the burgeoning UK life sciences sector, supporting the growth of medical technology and digital health companies.Summary of transaction details:Value: £21.26 million (€25 million)Sector: Healthcare & Biotech (Medtech, Diagnostics, Digital Health)Advisor: Not disclosedKey Entities: British Business Bank (Investor), EQT Life Sciences’ Health Economics 3 Fund (Target)Location: UK (beneficiary of investment focus)Note: This strategic fund commitment by the British Business Bank aims to support commercial-stage, de-risked companies that can improve patient care while simultaneously reducing healthcare costs, aligning with the UK's industrial growth strategy.